XML 74 R58.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 14, 2021
Jul. 31, 2022
Apr. 30, 2022
Mar. 31, 2021
Feb. 28, 2021
Jan. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Apr. 04, 2022
May 04, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Stock issued during period value new issues               $ 28,939,257    
Number of shares   486,145                
Accredited investors shares     165,738              
Equity consideration (fair value) $ 584,244                  
Transaction expenses     $ 600,000              
Share price     $ 30.75           $ 30.75  
Options to acquire shares     144,191       144,191      
Weighted exercise price     $ 10.71              
Warrants to purchase shares     4,424              
Exercise price     $ 7.32              
Shares Issued, Price Per Share     $ 27.13              
Cash                   $ 500,000
Cash consideration   $ 10,000,000.0                
Granted             173,959      
Restricted stock award, gross             $ 4,361,698      
Share-based compensation             2,702,633 2,668,892    
Accrued liability               $ 1,038,183    
Unrecognized share-based compensation expense             $ 2,275,010      
Unrecognized share-based compensation expense period for recognition             8 months 12 days      
Precision Healing Inc [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Cash consideration     $ 125,966              
Payment of contingent consideration     $ 10,000,000.0              
Rochal Industries LLC [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares       20,834 20,834          
Milestone payments       $ 750,000 $ 750,000          
Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares               1,265,000    
Stock issued during period value new issues               $ 1,265    
Accredited investors shares             457,424      
Warrants to purchase shares     12,301              
Exercise price     $ 12.05              
Equity Exchange Agreement [Member] | Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares           29,536        
Stock issued during period value new issues           $ 1,000,000        
Underwriting Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares         1,100,000          
Sale of stock, price per share         $ 25.00          
Accredited investors shares         165,000          
Proceeds from offering         $ 28,900,000          
Asset Purchase Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Payments to acquire assets $ 496,100                  
Issuance of common stock for purchase of assets 14,369                  
Net liabilities $ 3,900                  
Equity consideration (fair value) $ 584,244                  
Purchase Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares   94,798                
Proceeds from offering   $ 1,950,000                
Payments to acquire assets   $ 7,600,000                
Issuance of common stock for purchase of assets   291,686                
Cash   $ 1,600,000                
Restated 2014 Omnibus Long Term Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares available for issuance             1,520,332      
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares             479,668